Drug
Fluzone High-Dose
Fluzone High-Dose is a pharmaceutical drug with 6 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
1(17%)
Results Posted
100%(4 trials)
Phase Distribution
Ph phase_1
1
17%
Ph phase_3
1
17%
Ph phase_4
4
67%
Phase Distribution
1
Early Stage
0
Mid Stage
5
Late Stage
Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
Phase 3Large-scale testing
1(16.7%)
Phase 4Post-market surveillance
4(66.7%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
6
all time
Status Distribution
Active(1)
Completed(4)
Other(1)
Detailed Status
Completed4
unknown1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
6
Active
1
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 11 (16.7%)
Phase 31 (16.7%)
Phase 44 (66.7%)
Trials by Status
unknown117%
completed467%
recruiting117%
Recent Activity
1 active trials
Showing 5 of 6
recruitingphase_4
B Cell and Antibody Response to Seasonal Influenza Vaccines in Younger and Older Adults
NCT04101838
completedphase_4
Immunogenicity Trial of Egg- Versus Non-Egg-Based Influenza Vaccines Among HCP
NCT03722589
completedphase_4
Gene Signatures of Influenza Vaccine Responses in Older Adults
NCT03603509
unknownphase_3
Intradermal Influenza Vaccine With Topical Imiquimod in Elderly and Chronic Illness Patients
NCT04143451
completedphase_4
FLUAD® vs. Fluzone® High-Dose Study
NCT03183908
Clinical Trials (6)
Showing 6 of 6 trials
NCT04101838Phase 4
B Cell and Antibody Response to Seasonal Influenza Vaccines in Younger and Older Adults
NCT03722589Phase 4
Immunogenicity Trial of Egg- Versus Non-Egg-Based Influenza Vaccines Among HCP
NCT03603509Phase 4
Gene Signatures of Influenza Vaccine Responses in Older Adults
NCT04143451Phase 3
Intradermal Influenza Vaccine With Topical Imiquimod in Elderly and Chronic Illness Patients
NCT03183908Phase 4
FLUAD® vs. Fluzone® High-Dose Study
NCT02263040Phase 1
A Pilot Study to Assess the Immunogenicity and Reactogenicity of High Versus Standard Dose TIV
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6